LY6G5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.354800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.240200E-01
Normal-vs-Stage2
4.364000E-01
Normal-vs-Stage3
3.352800E-01
Normal-vs-Stage4
4.000600E-01
Stage1-vs-Stage2
8.146400E-01
Stage1-vs-Stage3
3.032400E-01
Stage1-vs-Stage4
8.040400E-01
Stage2-vs-Stage3
2.037400E-01
Stage2-vs-Stage4
6.368200E-01
Stage3-vs-Stage4
3.969200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.446000E-01
Normal-vs-AfricanAmerican
3.311800E-01
Normal-vs-Asian
4.113800E-01
Caucasian-vs-AfricanAmerican
8.090000E-02
Caucasian-vs-Asian
5.142200E-01
AfricanAmerican-vs-Asian
2.359800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.275600E-01
Normal-vs-Female
4.476400E-01
Male-vs-Female
4.721000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.920600E-01
Normal-vs-Age(41-60Yrs)
4.271400E-01
Normal-vs-Age(61-80Yrs)
4.428400E-01
Normal-vs-Age(81-100Yrs)
4.093400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.392200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.541000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.984400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.724200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.665000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.453400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.403800E-01
Normal-vs-Daily Drinker
4.120600E-01
Normal-vs-Weekly Drinker
4.265800E-01
Normal-vs-Occasional Drinker
4.364400E-01
Normal-vs-Social Drinker
4.552000E-01
Non Drinker-vs-Daily Drinker
5.617400E-01
Non Drinker-vs-Weekly Drinker
8.059600E-01
Non Drinker-vs-Occasional Drinker
9.368400E-01
Non Drinker-vs-Social Drinker
8.174000E-01
Daily Drinker-vs-Weekly Drinker
7.802800E-01
Daily Drinker-vs-Occasional Drinker
6.338000E-01
Daily Drinker-vs-Social Drinker
4.309800E-01
Weekly Drinker-vs-Occasional Drinker
8.640800E-01
Weekly Drinker-vs-Social Drinker
6.442800E-01
Occasional Drinker-vs-Social Drinker
7.655600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.426400E-01
Normal-vs-Grade 2
2.373200E-01
Normal-vs-Grade 3
2.388800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.302200E-01
Grade 1-vs-Grade 3
7.569600E-01
Grade 1-vs-Grade 4
3.426400E-01
Grade 2-vs-Grade 3
4.922600E-01
Grade 2-vs-Grade 4
2.373200E-01
Grade 3-vs-Grade 4
2.388800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.357400E-01
Normal-vs-NonDiabetic
4.395600E-01
Diabetic-vs-NonDiabetic
8.898600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.108800E-01
Normal-vs-NoPancreatitis
4.274400E-01
Pancreatitis-vs-NoPancreatitis
7.053000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.389400E-01
Normal-vs-N1
4.295800E-01
N0-vs-N1
7.690400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.351200E-01
Normal-vs-TP53-NonMutant
4.646200E-01
TP53-Mutant-vs-TP53-NonMutant
4.819400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
